Stramsen Biotech's last reported valuation, Oct 2023. Nothing priced has surfaced since.
- ·Watch Stramsen Biotech: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Stramsen Biotech funding history
No funding rounds for Stramsen Biotech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Stramsen Biotech valuation
Stramsen Biotech's last reported valuation was $807 million in Oct 2023. No priced round, secondary trade or fund mark has surfaced since.
How much has Stramsen Biotech raised?
Stramsen Biotech has filed 1 Form D with the SEC, most recently in May 2024 (null sold).
How Stramsen Biotech's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Stramsen Biotech, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →
Frequently asked about Stramsen Biotech
- What is Stramsen Biotech worth?
- Stramsen Biotech is valued at $807.0M as of Oct 2026. Stramsen Biotech's last reported valuation, Oct 2023. Nothing priced has surfaced since.
- How much has Stramsen Biotech raised?
- Stramsen Biotech has raised $35.0M in total funding across its recorded rounds.